Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-02-002384
Filing Date
2002-12-06
Accepted
2002-12-06 10:12:31
Documents
3
Group Members
ORBIMED ADVISORS INC.ORBIMED ADVISORS LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A - ORBIMED ADVISORS INC - TRIANGLE sc13ga_120502-triangle.txt SC 13G/A 10171
3 JOINT FILING AGREEMENT ex1-1_120502.txt EX-1.1 1956
4 STATEMENT OF CONTROL PERSON ex2-1_110502.txt EX-2.1 814
  Complete submission text file 0000947871-02-002384.txt   15218
Mailing Address 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Subject) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47359 | Film No.: 02850389
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 41 MADISON AVENUE 40TH FLOOR NEW YORK NY 10010 2126850800
ORBIMED ADVISERS INC /CT (Filed by) CIK: 0001033248 (see all company filings)